Chronic lung disease · preterm neonates after extubation
Nasal intermittent positive pressure ventilation (NIPPV) showed no clear difference in chronic lung disease (oxygen supplementation at 36 weeks) compared with nasal continuous positive airway pressure (NCPAP) (moderate certainty).
1 finding from 1 review
Pulmonary air leak · preterm neonates after extubation
Nasal intermittent positive pressure ventilation (NIPPV) may leads to lower pulmonary air leak compared with nasal continuous positive airway pressure (NCPAP) (low certainty).
1 finding from 1 review
Mortality before hospital discharge · preterm neonates after extubation
Nasal intermittent positive pressure ventilation (NIPPV) showed no clear difference in mortality (defined as death before discharge) compared with nasal continuous positive airway pressure (NCPAP) (low certainty).
1 finding from 1 review
Respiratory failure · )
Nasal intermittent positive pressure ventilation (NIPPV) probably leads to lower respiratory failure compared with nasal continuous positive airway pressure (NCPAP) (by population) (moderate certainty).
1 finding from 1 review
Need for endotracheal tube ventilation · )
Nasal intermittent positive pressure ventilation (NIPPV) probably leads to lower need for endotracheal tube ventilation compared with nasal continuous positive airway pressure (NCPAP) (by population) (moderate certainty).
1 finding from 1 review
Death during study period · )
Nasal intermittent positive pressure ventilation (NIPPV) showed no clear difference in mortality during study period compared with nasal continuous positive airway pressure (NCPAP) (by population) (low certainty).
1 finding from 1 review
Chronic lung disease · )
Nasal intermittent positive pressure ventilation (NIPPV) may leads to lower chronic lung disease compared with nasal continuous positive airway pressure (NCPAP) (by population) (low certainty).
1 finding from 1 review
Pneumothorax · )
Nasal intermittent positive pressure ventilation (NIPPV) showed no clear difference in pneumothorax compared with nasal continuous positive airway pressure (NCPAP) (by population) (low certainty).
1 finding from 1 review
Severe (grade 3 or greater) intraventricular hemorrhage (IVH) on cranial ultrasound ‐ not reported · )
Nasal intermittent positive pressure ventilation (NIPPV) showed no clear difference in severe intraventricular hemorrhage (grade III/IV) compared with nasal continuous positive airway pressure (NCPAP) (by population) (low certainty).
1 finding from 1 review
Recurrent seizure at 6 months · children with febrile seizures
It is very uncertain whether intermittent phenobarbital changes recurrent seizure at 6 months compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Recurrent seizure at 12 months · children with febrile seizures
Intermittent phenobarbital showed no clear difference in recurrent seizure at 12 months compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Recurrent seizure at 18 months · children with febrile seizures
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Recurrent seizure at 24 months · children with febrile seizures
Intermittent phenobarbital showed no clear difference in recurrent seizure at 24 months compared with placebo or no treatment (low certainty).
1 finding from 1 review
Recurrent seizure at 36 months · children with febrile seizures
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Recurrent seizure at 48 months · children with febrile seizures
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Recurrent seizure at 60 months or greater · children with febrile seizures
It is very uncertain whether intermittent phenobarbital changes recurrent seizure at 60 months or greater compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Recurrent seizure at 6 months · children with febrile seizures
Intermittent oral clobazam may leads to lower recurrent seizure at 6 months compared with placebo (low certainty).
1 finding from 1 review
Recurrent seizure at 12 months · children with febrile seizures
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Recurrent seizure at 18 months · children with febrile seizures
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Recurrent seizure at 24 months · children with febrile seizures
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found